Case Report: Thymoma-associated stiff person syndrome and myasthenia gravis: an index case with exploratory exome sequencing and review of reported cases - Report - MDSpire

Case Report: Thymoma-associated stiff person syndrome and myasthenia gravis: an index case with exploratory exome sequencing and review of reported cases

  • By

  • Lu Zhao

  • Linan Fang

  • Mingbo Tang

  • Kewei Zhang

  • Wei Liu

  • Min Qiang

  • May 1, 2026

  • 0 min

Share

Clinical Report: Exploratory Exome Sequencing in Thymoma-Related SPS and MG

Overview

This report details a case of a 55-year-old female with thymoma-related stiff person syndrome (SPS) and myasthenia gravis (MG), highlighting the diagnostic challenges and treatment outcomes. Whole-exome sequencing revealed significant genetic mutations, contributing to the understanding of the immunopathogenic mechanisms involved.

Background

Thymoma is frequently associated with myasthenia gravis, but the coexistence of stiff person syndrome is rare, complicating diagnosis and treatment. Understanding the immunopathogenic mechanisms is crucial for effective management of these overlapping syndromes, which can significantly impact patient quality of life and treatment strategies.

Data Highlights

FindingDetails
Patient Age55 years
SymptomsGait instability, axial rigidity, dysarthria, dysphagia
Serological FindingsElevated GAD65 and AChR antibodies
Thymoma HistologyWHO B1/B2 mixed
Genetic FindingsCACNA1A mutation, immune-signaling gene variants

Key Findings

  • The patient exhibited significant clinical symptoms including gait instability and dysphagia.
  • Serological testing revealed elevated levels of GAD65 and AChR antibodies.
  • Thymoma was confirmed via chest CT, indicating an anterior mediastinal mass.
  • Whole-exome sequencing identified a CACNA1A frameshift mutation and variants in immune-signaling genes.
  • Management with immunotherapy and thymectomy led to notable clinical improvement.
  • Literature review identified seven additional cases with similar findings and positive outcomes following treatment.

Clinical Implications

Clinicians should consider the potential for overlapping syndromes in patients with thymoma, particularly the association with SPS and MG. Comprehensive diagnostic evaluations, including serological and genetic testing, are essential for guiding treatment strategies and improving patient outcomes.

Conclusion

Thymoma-related SPS and MG represent a complex clinical challenge, necessitating a multidisciplinary approach to diagnosis and management. The integration of clinical, genetic, and literature findings supports a unified understanding of the underlying mechanisms.

References

  1. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update - PMC
  2. Stiff-person syndrome and related disorders — diagnosis, mechanisms and therapies | Nature Reviews Neurology
  3. Paraneoplastic autoimmune neurologic disorders associated with thymoma - PubMed
  4. Acta Neuropathologica — A Novel Mitochondrial Disease Phenotype Associated with Familial Late-Onset Axial Myopathy and Encephalopathy
  5. Brain — Variants in HMGCS1 Lead to Rigid Spine Syndrome Treatable with Mevalonic Acid in an Animal Study
  6. Acta Neuropathologica — Mutations in the SMPX gene linked to distal myopathy characterized by protein inclusions
  7. The Journal of Infectious Diseases — Parvovirus B19 and Human Herpes Virus 6B and 7 Are Frequently Found DNA Viruses in the Human Thymus But Show No Definitive Link With Myasthenia Gravis
  8. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update - PMC
  9. Stiff-person syndrome and related disorders — diagnosis, mechanisms and therapies | Nature Reviews Neurology
  10. Paraneoplastic autoimmune neurologic disorders associated with thymoma - PubMed

Original Source(s)

Related Content